Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

131.75
Delayed Data
As of 4:00pm ET
 -1.47 / -1.10%
Today’s Change
109.32
Today|||52-Week Range
137.08
+14.36%
Year-to-Date
Karyopharm's Liposarcoma Candidate Superior in Phase II Study
11:29am / Zacks.com - Paid Partner Content
Dow Jones Closes at New High
Sep 14 / GuruFocus News - Paid Partner Content
Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake
11:04am / Zacks.com - Paid Partner Content
AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs
Sep 14 / Zacks.com - Paid Partner Content
Top Research Reports for Northrop Grumman, BNY Mellon & Celgene
Sep 20 / Zacks.com - Paid Partner Content
Novartis Announces Long-Term Data on Psoriasis Drug Cosentyx
Sep 14 / Zacks.com - Paid Partner Content
Johnson & Johnson Stock Sinks, Goldman Downgrades to 'Sell'
Sep 20 / TheStreet.com - Paid Partner Content
Abbott's (ABT) FreeStyle Libre Gets UK Reimbursement Nod
Sep 14 / Zacks.com - Paid Partner Content
Pfizer takes on J&J with antitrust lawsuit
Sep 20 / FT.com - Paid Partner Content
Facebook: We won't allow users to profit from fake news and violence
Sep 13 / CNNMoney.com
Here's Why These 3 Biotech Stocks Might Stop Rallying
Sep 20 / Zacks.com - Paid Partner Content
Integra Divests Assets to Natus, Paves Way for Codman Buyout
Sep 13 / Zacks.com - Paid Partner Content
Alkermes' ARISTADA Shows Better Results to Treat Schizophrenia
Sep 19 / Zacks.com - Paid Partner Content
Facebook acts to protect brands with new ad placement rules
Sep 13 / FT.com - Paid Partner Content
Crazy Weak U.S. Dollar Will Make These 10 Companies Huge Winners
Sep 19 / TheStreet.com - Paid Partner Content
Achillion's HCV Partnership with J&J Terminated, Stock Falls
Sep 12 / Zacks.com - Paid Partner Content
J&J's (JNJ) Psoriasis Drug Guselkumab Gets CHMP Nod in EU
Sep 18 / Zacks.com - Paid Partner Content
3 Excellent Dividend ETFs for Turbulent Times
Sep 08 / Zacks.com - Paid Partner Content
Catalyst (CPRX) Focused on Two Lead Pipeline Candidates
Sep 18 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: UTX to Buy Rockwell Collins, Merck Secures EU Keytruda Approval
Sep 08 / Zacks.com - Paid Partner Content
This is a big week for Brexit. It's not going well
Sep 18 / CNNMoney.com
MedTech Hangs in the Balance as Obamacare Skinny Repeal Fails
Sep 07 / Zacks.com - Paid Partner Content
Neos Therapeutics ADHD Drug Adzenys Receives Approval in US
Sep 18 / Zacks.com - Paid Partner Content
J&J (JNJ) PAH Drug's U.S. Label Expanded for Pediatric Use
Sep 07 / Zacks.com - Paid Partner Content
S&P 500 Makes History, Steers Past 2500: Top 5 Gainers
Sep 18 / Zacks.com - Paid Partner Content
Fancy investing in a theme? There's an ETF for that
Sep 07 / FT.com - Paid Partner Content
Pfizer Xtandi Succeeds in Early Stage Prostate Cancer Study
Sep 15 / Zacks.com - Paid Partner Content
U.S. companies still hoarding cash overseas
Aug 23 / CNNMoney.com
Amgen/Allergan's Avastin Biosimilar Secures FDA Approval
Sep 15 / Zacks.com - Paid Partner Content
Norway's sovereign fund reveals interventionist streak
Aug 22 / FT.com - Paid Partner Content
Johnson & Johnson Is Getting Ready for Another Upside Breakout
Sep 15 / TheStreet.com - Paid Partner Content